USPTO serial 79368529
Serial No. 79368529
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 28, 2024
- Examiner
- MACKO, CINDY JOYCE SAVITR
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79368529?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John Alumit
John Alumit ALUMIT IP135 S. JACKSON STREET, SUITE 200GLENDALE, CA 91205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for medical purposes, namely, biological preparations for the treatment of Cancer, Autoimmune diseases, Neurological disorders, diabetes, Infections Transplant rejection, Cardiovascular diseases, Metabolic diseases, Neurodegenerative diseases, Bone diseases, Ophthalmologic diseases, Organ transplant rejection Inflammatory and autoimmune disorders, including allergies, Osteoporosis, Eye conditions, Migraines, High cholesterol, Nervous system disorders, Graft-versus-host disease, Viral infections, Gastrointestinal diseases, Respiratory diseases, Skin diseases, Arthritis; nutraceutical preparations for therapeutic or medical purposes, namely, nutraceutical preparations for the treatment of Cancer, Autoimmune diseases, Neurological disorders, diabetes, Infections Transplant rejection, Cardiovascular diseases, Metabolic diseases, Neurodegenerative diseases, Bone diseases, Ophthalmologic diseases, Organ transplant rejection Inflammatory and autoimmune disorders, including allergies, Osteoporosis, Eye conditions, Migraines, High cholesterol, Nervous system disorders, Graft-versus-host disease, Viral infections, Gastrointestinal diseases, Respiratory diseases, Skin diseases, Arthritis | ACTIVE | — |
| 035 | Online advertising on a computer network; advertising; publicity agency services; dissemination of advertising for others via an on-line communications network on the internet; advertising relating to pharmaceutical products and in-vivo imaging products; providing business information; sales promotion for others; import-export agency services; retail or wholesale store services for pharmaceutical drugs; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail or wholesale store services for pharmaceutical preparations; retail or wholesale store services for medical supplies | ACTIVE | — |
| 042 | Technological research in the field of drug discovery, drug development, drug process development, and drug manufacture | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bioworkshops (Suzhou) Limited
- Other trademarks owned by Bioworkshops (Suzhou) Limited
- Other trademarks owned by Bioworkshops (Suzhou) Limited
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 7, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 14, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 13, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 28, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 28, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 28, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 12, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 12, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 12, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 21, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 21, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 21, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 21, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 7, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 1, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 1, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 19, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 24, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 24, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 12, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 11, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 5, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 1, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 27, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |